Logiscreen

Pacira BioSciences Inc

$36.40
Market Cap 1.43B
ROE 2.1%
Gross Margin 77.0%
Debt/Equity 0.6
Current Ratio 5.0
Revenue QoQ 6.2%
EPS QoQ -2.1%
F-Score 7

About

Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine; and DepoDur (morphine sulfate extended-release liposome injection) is an extended-release, injectable formulation of morphine.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
213.35
vs median 36.93
P/B
1.68
vs median 2.32
ROE
0.01
vs median 0.09

Decent quality with acceptable fundamentals

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics